Chronic back pain often starts small but gradually affects every part of life. Experts explain why it worsens and why ...
São Paulo continues its internal restructuring process for the 2026 season, following a terrible year, especially in its ...
Lead product GelrinC®, a hydrogel synchronized erosion and resorbable implant, the only restorative product for knee cartilage repair, is a breakthrough effective and economical procedure to address a ...
The NCAA must still formally approve the rule change, but it is expected to pass, with a dealmaking frenzy to follow.
Sanuwave's end-to-end wound care portfolio of regenerative medicine products and product candidates help restore the body’s normal healing processes. Sanuwave applies and researches its patented ...
Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of ...
São Paulo continues its internal restructuring process for the 2026 season, after a terrible year, especially in its health ...
March Bio is continuing enrollment in the Phase 2 trial, with the Independent Data Monitoring Committee’s approval to advance to Simon Stage 2 of the Phase 2 trial. The Company anticipates presenting ...
TipRanks on MSN
Immix Biopharma announces positive phase 2 trial results
The latest announcement is out from Immix Biopharma ( (IMMX) ).
Investing.com -- Lyell Immunopharma Inc (NASDAQ:LYEL) stock rose 4.2% in premarket trading Monday after the clinical-stage biotech company reported promising data from its cancer therapy trials.
The Wyss Institute is proud to welcome three new Associate Faculty members: Ahmad (Mo) Khalil, Ph.D., Jarad Mason, Ph.D., and Chao-ting (Ting) Wu, Ph.D. Each has a history of collaborating with the ...
The Global Biomaterial Wound Dressing Market is poised for growth due to the rising incidence of chronic wounds and a growing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results